No abstract

The adsorption coefficient of racemic metalaxyl onto an agriculture soil was small and non-enantioselective. Biotransformation was the predominant pathway for the elimination of R-metalaxyl, while abiotic and biotransformation made a comparable contribution to the degradation of S-metalaxyl. Metalaxyl acid was the main transformation intermediate. The enantiomer fraction of metalaxyl decreased with an increase in its initial spike concentration or the presence of the co-constituents in metalaxyl commercial products. Under simulated solar irradiation, the presence of TiO2 promoted the overall transformation kinetics through enhanced biotransformation and extra photo-induced chemical reactions. The promotion was enantioselective and thereafter changed the enantiomer fraction. The results obtained in this study showed that some achiral parameters, although they have no direct impact on enantioselective reactions with enantiomers, can significantly affect the enantioselective transformation of racemic metalaxyl. Thus, our results indicate that the contribution of chemical interactions on the enantioselective transformation of chiral pesticides may be underestimated.

No abstract

No abstract

No abstract

Limited studies have attempted to evaluate pharmaceutical removal during the sidestream partial nitritation (PN) process. In this work, atenolol biodegradation by PN cultures was investigated by maintaining ammonium and pH at different levels. For the first time, free nitrous acid (FNA), other than ammonium, pH, and free ammonia, was demonstrated to inhibit atenolol removal, with biodegradation efficiencies of ∼98, ∼67, and ∼28% within 6 days at average FNA levels of 0, 0.03, and 0.19 mg-N L −1 , respectively. Ammonia-oxidizing bacteria (AOB)-induced metabolism was predominant despite varying FNA concentrations. In the absence of ammonium/FNA, atenolol was mostly biodegraded via AOB-induced metabolism (65%) and heterotroph-induced metabolism (33%). AOBinduced metabolism was largely inhibited (down to 29%) at 0.03 mg-N L −1 FNA, while ∼27 and ∼11% were degraded via heterotrophinduced metabolism and AOB-induced cometabolism, respectively. Higher FNA (0.19 mg-N L −1 ) substantially reduced atenolol biodegradation via heterotroph-induced metabolism (4%), AOB-induced metabolism (16%), and AOB-induced cometabolism (8%). Newly identified products and pathways were related to metabolic types and FNA levels: (i) deamination and decarbonylation (AOB-induced cometabolism, 0.03 mg-N L −1 FNA); (ii) deamination from atenolol acid (heterotrophic biodegradation); and (iii) nitro-substitution (reaction with nitrite). This suggests limiting FNA to realize simultaneous nitrogen and pharmaceutical removal during the sidestream process.

No abstract

No abstract